200 related articles for article (PubMed ID: 29109527)
1. The RNA binding protein La/SS-B promotes RIG-I-mediated type I and type III IFN responses following Sendai viral infection.
Mahony R; Broadbent L; Maier-Moore JS; Power UF; Jefferies CA
Sci Rep; 2017 Nov; 7(1):14537. PubMed ID: 29109527
[TBL] [Abstract][Full Text] [Related]
2. Middle East Respiratory Syndrome Coronavirus Nucleocapsid Protein Suppresses Type I and Type III Interferon Induction by Targeting RIG-I Signaling.
Chang CY; Liu HM; Chang MF; Chang SC
J Virol; 2020 Jun; 94(13):. PubMed ID: 32295922
[TBL] [Abstract][Full Text] [Related]
3. Human kinome analysis reveals novel kinases contributing to virus infection and retinoic-acid inducible gene I-induced type I and type III IFN gene expression.
Nousiainen L; Sillanpää M; Jiang M; Thompson J; Taipale J; Julkunen I
Innate Immun; 2013 Oct; 19(5):516-30. PubMed ID: 23405030
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylinositol-3-kinase and Akt are required for RIG-I-mediated anti-viral signalling through cross-talk with IPS-1.
Yeon SH; Song MJ; Kang HR; Lee JY
Immunology; 2015 Feb; 144(2):312-20. PubMed ID: 25158146
[TBL] [Abstract][Full Text] [Related]
5. Sendai virus pathogenesis in mice is prevented by Ifit2 and exacerbated by interferon.
Wetzel JL; Fensterl V; Sen GC
J Virol; 2014 Dec; 88(23):13593-601. PubMed ID: 25231314
[TBL] [Abstract][Full Text] [Related]
6. HOIL1 Is Essential for the Induction of Type I and III Interferons by MDA5 and Regulates Persistent Murine Norovirus Infection.
MacDuff DA; Baldridge MT; Qaqish AM; Nice TJ; Darbandi AD; Hartley VL; Peterson ST; Miner JJ; Iwai K; Virgin HW
J Virol; 2018 Dec; 92(23):. PubMed ID: 30209176
[TBL] [Abstract][Full Text] [Related]
7. The U-Rich Untranslated Region of the Hepatitis E Virus Induces Differential Type I and Type III Interferon Responses in a Host Cell-Dependent Manner.
Sooryanarain H; Heffron CL; Meng XJ
mBio; 2020 Jan; 11(1):. PubMed ID: 31937650
[TBL] [Abstract][Full Text] [Related]
8. The RNA binding protein Quaking represses host interferon response by downregulating MAVS.
Liao KC; Chuo V; Fagg WS; Bradrick SS; Pompon J; Garcia-Blanco MA
RNA Biol; 2020 Mar; 17(3):366-380. PubMed ID: 31829086
[TBL] [Abstract][Full Text] [Related]
9. Adenosine deaminase acting on RNA 1 limits RIG-I RNA detection and suppresses IFN production responding to viral and endogenous RNAs.
Yang S; Deng P; Zhu Z; Zhu J; Wang G; Zhang L; Chen AF; Wang T; Sarkar SN; Billiar TR; Wang Q
J Immunol; 2014 Oct; 193(7):3436-45. PubMed ID: 25172485
[TBL] [Abstract][Full Text] [Related]
10. MIP-T3 is a negative regulator of innate type I IFN response.
Ng MH; Ho TH; Kok KH; Siu KL; Li J; Jin DY
J Immunol; 2011 Dec; 187(12):6473-82. PubMed ID: 22079989
[TBL] [Abstract][Full Text] [Related]
11. A Single Amino Acid Substitution within the Paramyxovirus Sendai Virus Nucleoprotein Is a Critical Determinant for Production of Interferon-Beta-Inducing Copyback-Type Defective Interfering Genomes.
Yoshida A; Kawabata R; Honda T; Sakai K; Ami Y; Sakaguchi T; Irie T
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237838
[TBL] [Abstract][Full Text] [Related]
12. Arenaviral Nucleoproteins Suppress PACT-Induced Augmentation of RIG-I Function To Inhibit Type I Interferon Production.
Shao J; Huang Q; Liu X; Di D; Liang Y; Ly H
J Virol; 2018 Jul; 92(13):. PubMed ID: 29669840
[TBL] [Abstract][Full Text] [Related]
13. ATPase-driven oligomerization of RIG-I on RNA allows optimal activation of type-I interferon.
Patel JR; Jain A; Chou YY; Baum A; Ha T; García-Sastre A
EMBO Rep; 2013 Sep; 14(9):780-7. PubMed ID: 23846310
[TBL] [Abstract][Full Text] [Related]
14. Signaling Pathways of Type I and Type III Interferons and Targeted Therapies in Systemic Lupus Erythematosus.
Chyuan IT; Tzeng HT; Chen JY
Cells; 2019 Aug; 8(9):. PubMed ID: 31450787
[TBL] [Abstract][Full Text] [Related]
15. Sendai virus C proteins must interact directly with cellular components to interfere with interferon action.
Garcin D; Curran J; Kolakofsky D
J Virol; 2000 Oct; 74(19):8823-30. PubMed ID: 10982324
[TBL] [Abstract][Full Text] [Related]
16. A functional C-terminal TRAF3-binding site in MAVS participates in positive and negative regulation of the IFN antiviral response.
Paz S; Vilasco M; Werden SJ; Arguello M; Joseph-Pillai D; Zhao T; Nguyen TL; Sun Q; Meurs EF; Lin R; Hiscott J
Cell Res; 2011 Jun; 21(6):895-910. PubMed ID: 21200404
[TBL] [Abstract][Full Text] [Related]
17. Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms.
Bitko V; Musiyenko A; Bayfield MA; Maraia RJ; Barik S
J Virol; 2008 Aug; 82(16):7977-87. PubMed ID: 18550659
[TBL] [Abstract][Full Text] [Related]
18. IFI16 directly senses viral RNA and enhances RIG-I transcription and activation to restrict influenza virus infection.
Jiang Z; Wei F; Zhang Y; Wang T; Gao W; Yu S; Sun H; Pu J; Sun Y; Wang M; Tong Q; Gao C; Chang KC; Liu J
Nat Microbiol; 2021 Jul; 6(7):932-945. PubMed ID: 33986530
[TBL] [Abstract][Full Text] [Related]
19. Phosphatase Cdc25A Negatively Regulates the Antiviral Immune Response by Inhibiting TBK1 Activity.
Qi D; Hu L; Jiao T; Zhang T; Tong X; Ye X
J Virol; 2018 Oct; 92(19):. PubMed ID: 30021902
[TBL] [Abstract][Full Text] [Related]
20. TRIM13 is a negative regulator of MDA5-mediated type I interferon production.
Narayan K; Waggoner L; Pham ST; Hendricks GL; Waggoner SN; Conlon J; Wang JP; Fitzgerald KA; Kang J
J Virol; 2014 Sep; 88(18):10748-57. PubMed ID: 25008915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
